| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 41,881 | 44,258 | 45,006 | 46,220 | | Cost of Revenue | 9,558 | 10,608 | 11,547 | 11,940 | | | Gross Profit |
-
| 33,650 | 33,459 | 34,280 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,239 | 22,638 | 21,037 | 20,111 | | Non Recurring |
-
| 57,579 |
-
|
-
| | Others | 9,375 | 48,281 | 9,794 | 21,514 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (94,848) | 2,628 | (7,345) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,709 | (94,848) | 2,628 | (7,075) | | Interest Expense | 1,363 | 1,506 | 1,960 | 2,357 | | Income Before Tax | 1,346 | (96,354) | 668 | (9,432) | | Income Tax Expense | (126) | (37,928) | (316) | (4,519) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,472 | (58,426) | 984 | (5,183) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,472 | (58,426) | 984 | (5,183) | | Preferred Stock And Other Adjustments | (1,121) | (1,235) | (801) |
-
| | | Net Income Applicable To Common Shares | $351 | ($59,661) | $183 | ($5,183) |
|
0.51% Nasdaq 
Income Statement
